AU2002212200A1 - Controlled release pharmaceutical pellet compositions for reducing side effects of drugs - Google Patents

Controlled release pharmaceutical pellet compositions for reducing side effects of drugs

Info

Publication number
AU2002212200A1
AU2002212200A1 AU2002212200A AU1220002A AU2002212200A1 AU 2002212200 A1 AU2002212200 A1 AU 2002212200A1 AU 2002212200 A AU2002212200 A AU 2002212200A AU 1220002 A AU1220002 A AU 1220002A AU 2002212200 A1 AU2002212200 A1 AU 2002212200A1
Authority
AU
Australia
Prior art keywords
drugs
side effects
controlled release
release pharmaceutical
reducing side
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212200A
Other languages
English (en)
Inventor
Ann Debunne
Jean Paul Remon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Gent
Original Assignee
Universiteit Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0021341A external-priority patent/GB0021341D0/en
Priority claimed from EP01201554A external-priority patent/EP1252886A1/fr
Application filed by Universiteit Gent filed Critical Universiteit Gent
Publication of AU2002212200A1 publication Critical patent/AU2002212200A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU2002212200A 2000-08-31 2001-08-31 Controlled release pharmaceutical pellet compositions for reducing side effects of drugs Abandoned AU2002212200A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0021341A GB0021341D0 (en) 2000-08-31 2000-08-31 NSAID Drug formulation for Pelletisation
GB0021341.3 2000-08-31
EP01201554.1 2001-04-27
EP01201554A EP1252886A1 (fr) 2001-04-27 2001-04-27 Compositions pharmaceutiques en forme de pellet pour libération contrôlée
PCT/EP2001/010168 WO2002017877A2 (fr) 2000-08-31 2001-08-31 Compositions pour granules pharmaceutiques a liberation controlee destinees a limiter les effets secondaires de medicaments

Publications (1)

Publication Number Publication Date
AU2002212200A1 true AU2002212200A1 (en) 2002-03-13

Family

ID=26076892

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212200A Abandoned AU2002212200A1 (en) 2000-08-31 2001-08-31 Controlled release pharmaceutical pellet compositions for reducing side effects of drugs

Country Status (2)

Country Link
AU (1) AU2002212200A1 (fr)
WO (1) WO2002017877A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
JP2006516642A (ja) * 2003-02-03 2006-07-06 シャイア ラボラトリーズ，インコーポレイテッド 薬物製剤およびメチル化シクロデキストリン結晶を用いた送達
WO2006011044A1 (fr) * 2004-07-22 2006-02-02 Pfizer Products Inc. Compositions a base de cyclodextrine amorphe
EP2841058A1 (fr) * 2012-04-23 2015-03-04 Cadila Healthcare Limited Compositions pharmaceutiques à libération retardée de salsalate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639637A (en) * 1968-04-23 1972-02-01 Richardson Merrell Inc Water dispersible diethylstilbestrol compositions
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
US5362860A (en) * 1993-02-01 1994-11-08 Warner-Lambert Company Neutral stabilization complex for CI-979 HCl, a cognition activator
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
AU9062998A (en) * 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)

Also Published As

Publication number Publication date
WO2002017877A3 (fr) 2002-08-08
WO2002017877A2 (fr) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2002229140A1 (en) Controlled release pharmaceutical composition
HUP0301921A3 (en) Sustained release pharmaceutical compositions for paranteral administration of hydrophilic compounds
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
GB0025208D0 (en) Delayed release pharmaceutical formulations
AU2276801A (en) Extended release oral dosage composition
AU2277101A (en) Stable extended release oral dosage composition
AU2003213151A1 (en) Controlled release solid dosage carbamazepine formulations
AU2001231000A1 (en) Dry powder formulations of antihistamine for nasal administration
AU2001248769A1 (en) Time-release coated solid compositions for oral administration
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
AU2002248377A1 (en) A controlled release pharmaceutical composition
EP1424994A4 (fr) Preparation d'une composition pharmaceutique a liberation prolongee
AUPR602501A0 (en) Sustained release pharmaceutical composition
EP1189597A4 (fr) Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes
AU2001287977A1 (en) Controlled release formulations for oral administration
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
AU2002228119A1 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
HUP0302522A3 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
AU2001248336A1 (en) Controlled release oral solid forms containing mesalazine as active agent
AU2001232948A1 (en) Controlled release of drugs
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
AU2001252296A1 (en) A peroral pharmaceutical formulation for controlled release of a drug
AU2002351388A1 (en) Methods and compositions for controlled release of drugs